NCT00901251CompletedNot Applicable
Reproducibility Study of OABSS and Its Response to Treatment - Part 1: Reproducibility -
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Astellas Pharma Inc
- Enrollment
- 50
- Primary Endpoint
- OABSS
Study Overview
Brief Summary
The purpose of this study is to evaluate the reproducibility of over active bladder symptom score (OABSS) in Asian countries.
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Symptoms OAB for 3 months or longer
- •At least 1 urgency episode in last 3 days
- •Symptoms of OAB as verified by the screening 3-day bladder diary, defined by:
- •Number of micturition ≥8 times/day
- •Number of urgency episode in 3 days ≥1
Exclusion Criteria
- •Indwelling catheters or practicing intermittent self-catheterization
- •Symptomatic urinary tract infection, chronic inflammation
- •Diabetic neuropathy
Outcomes
Primary Outcomes
OABSS
Time Frame: Weeks of 0 and 2
Secondary Outcomes
- 3-day micturition diary(2 times in 2-week interval)
Investigators
Similar Trials
Completed
Not Applicable
Reproducibility Study of Overactive Bladder Symptom Score [OABSS]Overactive BladderNCT01122550Astellas Pharma Inc50
Completed
Phase 4
A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin TreatmentOver Active BladderNCT01318837Astellas Pharma Inc100
Completed
Not Applicable
A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to TreatmentOveractive BladderNCT01122563Astellas Pharma Inc55
Completed
Phase 4
Reproducibility Study of OABSS and Its Response to TreatmentOveractive BladderNCT02667470Astellas Pharma Inc50
Completed
Not Applicable
Reliability of Polish-Version Overactive Bladder Syndrom Scores (OABSS)Urinary IncontinenceOveractive BladderNCT03801239Medical University of Lublin822